PainChek在老年综合医院痴呆患者中的心理测量学特性评估
该横断面心理测量学研究在伦敦两家综合医院的六个老年医疗病房中,对63例临床诊断为痴呆的患者(平均84岁,77%为中重度痴呆)使用PainChek电子疼痛评估工具,共进行216次评估。结果显示PainChek在静息和运动后均具有良好的评分者间信度、内部一致性和与PAINAD的并发效度,聚合效度与区分效度也得到支持。结论认为PainChek是用于综合医院痴呆患者疼痛评估的有效且可靠工具,但需进一步考虑临床实施。
要点
- PainChek在痴呆患者静息和运动后均显示良好信度与效度。
- 与PAINAD的并发效度运动后(0.787)高于静息(0.528)。
- 研究支持PainChek用于综合医院痴呆患者疼痛评估。
核心结论
- PainChek是用于综合医院痴呆患者疼痛评估的有效且可靠工具。
- 进一步需要考虑将其实施到该临床环境中。
研究设计与样本
- 横断面心理测量学研究,纳入63例临床诊断痴呆患者,平均84岁(SD 6.7),59%女性,77%中重度痴呆。
- 研究地点为英国大伦敦地区两家综合医院的六个老年医疗病房。
- 共进行216次评估,检验评分者间信度(Cohen's kappa)、内部一致性(Cronbach's alpha)、与PAINAD的并发效度(Pearson系数)、与SM-EOLD的聚合效度及区分效度。
主要发现
- 评分者间信度静息为0.714(95%CI 0.562至0.81),运动后为0.817(95%CI 0.692至0.894)。
- 内部一致性静息为0.755,运动后为0.833。
- 与PAINAD的并发效度静息为0.528(95%CI 0.317至0.690),运动后为0.787(95%CI 0.604至0.891)。
- 与SM-EOLD的聚合效度静息为-0.555(95%CI -0.726至-0.318),运动后为-0.5644(95%CI -0.733至-0.331)。
- 区分效度(静息与运动后比较)具有显著性。
关键数值与推荐
- 评分者间信度(Cohen's kappa):静息0.714(95%CI 0.562至0.81),运动后0.817(95%CI 0.692至0.894)。
- 内部一致性(Cronbach's alpha):静息0.755,运动后0.833。
- 与PAINAD的并发效度(Pearson系数):静息0.528(95%CI 0.317至0.690),运动后0.787(95%CI 0.604至0.891)。
- 与SM-EOLD的聚合效度(Pearson系数):静息-0.555(95%CI -0.726至-0.318),运动后-0.5644(95%CI -0.733至-0.331)。
临床怎么用
- 对于综合医院中临床诊断痴呆的老年患者,可使用PainChek进行疼痛评估。
- 评估时可分别在静息和运动后状态下进行,以获取更全面的疼痛信息。
- 临床实施时需结合具体环境进一步考虑相关因素。
局限性
- 原文未报告局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pain is common in people with dementia in general hospitals. This can be difficult to identify. OBJECTIVES: To evaluate the psychometric properties of PainChek electronic pain assessment tool. DESIGN: Cross-sectional psychometric study. SETTING: Six medical care of older people wards from two general hospitals in greater London, UK. SUBJECTS: 63 people with clinical diagnosis of dementia: mean 84 years (SD 6.7), 59% female, 69% living in their own homes, 64% white British, 77% moderate/severe dementia. METHOD: Psychometric evaluation of PainChek, a point-of-care electronic pain assessment tool combining artificial intelligence, facial analysis and smartphone technology. From a total of 216 assessments, we tested PainChek's inter-rater reliability (IRR) (Cohen's kappa), internal consistency (Cronbach's alpha) and concurrent validity (Pearson's coefficient) between PainChek and Pain Assessment in Advanced Dementia (PAINAD) scores at rest and post-movement [95% confidence interval (95% CI) where appropriate]. We assessed convergent validity with Symptom Management-End of Life in Dementia scale (SM-EOLD) (Pearson's coefficient) and discriminant validity (rest vs post-movement). RESULTS: IRR was 0.714 (95% CI 0.562 to 0.81) (rest) and 0.817 (95% CI 0.692 to 0.894) (post-movement). Internal consistency was 0.755 (rest) and 0.833 (post-movement). Concurrent validity with PAINAD was 0.528 (95% CI 0.317 to 0.690) (rest) and 0.787 (0.604 to 0.891) (post-movement). Convergent validity with SM-EOLD was -0.555 (95% CI -0.726 to -0.318) (rest) and -0.5644 (95% CI -0.733 to -0.331) (post-movement). Discriminant validity was significant. CONCLUSIONS: PainChek is a valid and reliable pain assessment tool for people with dementia in general hospitals. Further consideration will be needed for implementation into this setting.
引用
- Sampson EL, Davies N, Vickerstaff V, et al. Evaluation of the psychometric properties of PainChek in older general hospital patients with dementia. Age Ageing. 2025. PMID: 39967417. doi:10.1093/ageing/afaf027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。